Zymergen Inc. (NASDAQ:ZY) has seen 0.95 million shares traded in the last trading session. The company, currently valued at $1.37B, closed the last trade at $14.03 per share which meant it gained $0.64 on the day or 4.82% during that session. The ZY stock price is -270.63% off its 52-week high price of $52.00 and 44.05% above the 52-week low of $7.85. The 3-month trading volume is 2.75 million shares.
The consensus among analysts is that Zymergen Inc. (ZY) is a Hold stock at the moment, with a recommendation rating of 3.10. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 5 out of 7 have rated it as a Hold, with 0 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.87.
Zymergen Inc. (NASDAQ:ZY) trade information
Sporting 4.82% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the ZY stock price touched $14.03 or saw a rise of 4.43%. Year-to-date, Zymergen Inc. shares have moved -62.72%, while the 5-day performance has seen it change 4.97%. Over the past 30 days, the shares of Zymergen Inc. (NASDAQ:ZY) have changed -2.87%.
Wall Street analysts have a consensus price target for the stock at $10.40, which means that the shares’ value could drop -34.9% from current levels. The projected low price target is $7.00 while the price target rests at a high of $13.00. In that case, then, we find that the current price level is 7.34% off the targeted high while a plunge would see the stock lose 50.11% from current levels.
Zymergen Inc. (ZY) estimates and forecasts
5 analysts offering their estimates for the company have set an average revenue estimate of $5.89 million for the current quarter. 5 have an estimated revenue figure of $4.87 million for the next quarter concluding in Sep 2021.
Zymergen Inc. is expected to release its next earnings report on May 24 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Zymergen Inc. (NASDAQ:ZY)’s Major holders
Insiders own 8.92% of the company shares, while shares held by institutions stand at 58.59% with a share float percentage of 64.32%. Investors are also buoyed by the number of investors in a company, with Zymergen Inc. having a total of 106 institutions that hold shares in the company. The top two institutional holders are SB Investment Advisers (UK) LTD with over 26.61 million shares worth more than $1.06 billion. As of Jun 29, 2021, SB Investment Advisers (UK) LTD held 25.99% of shares outstanding.
The other major institutional holder is Baillie Gifford and Company, with the holding of over 2.82 million shares as of Jun 29, 2021. The firm’s total holdings are worth over $112.91 million and represent 2.76% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ARK ETF Tr-ARK Genomic Revolution ETF and JP Morgan Small Cap Growth Fund. As of Jul 30, 2021, the former fund manager holds about 1.03% shares in the company for having 1.06 million shares of worth $36.72 million while later fund manager owns 0.84 million shares of worth $33.57 million as of Jun 29, 2021, which makes it owner of about 0.82% of company’s outstanding stock.